Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.35 - $0.53 $254 - $385
728 Added 4.68%
16,281 $8,000
Q3 2023

Nov 13, 2023

SELL
$0.38 - $0.58 $1,121 - $1,712
-2,952 Reduced 15.95%
15,553 $6,000
Q2 2023

Jul 31, 2023

SELL
$0.39 - $0.94 $567 - $1,367
-1,455 Reduced 7.29%
18,505 $8,000
Q1 2023

May 10, 2023

SELL
$0.79 - $1.91 $12,243 - $29,601
-15,498 Reduced 43.71%
19,960 $16,000
Q4 2022

Feb 07, 2023

SELL
$1.41 - $2.5 $1,181 - $2,095
-838 Reduced 2.31%
35,458 $55,000
Q3 2022

Nov 14, 2022

SELL
$1.66 - $2.79 $6,806 - $11,439
-4,100 Reduced 10.15%
36,296 $63,000
Q2 2022

Aug 12, 2022

SELL
$1.44 - $3.98 $46,056 - $127,296
-31,984 Reduced 44.19%
40,396 $70,000
Q1 2022

May 16, 2022

BUY
$2.97 - $5.2 $61,876 - $108,336
20,834 Added 40.42%
72,380 $260,000
Q4 2021

Feb 14, 2022

BUY
$4.99 - $7.46 $10,004 - $14,957
2,005 Added 4.05%
51,546 $257,000
Q3 2021

Nov 15, 2021

SELL
$7.16 - $9.69 $95,249 - $128,906
-13,303 Reduced 21.17%
49,541 $355,000
Q2 2021

Aug 13, 2021

BUY
$6.23 - $10.03 $70,486 - $113,479
11,314 Added 21.96%
62,844 $583,000
Q1 2021

May 14, 2021

BUY
$8.81 - $16.96 $49,001 - $94,331
5,562 Added 12.1%
51,530 $478,000
Q4 2020

Feb 12, 2021

BUY
$8.5 - $12.85 $8,296 - $12,541
976 Added 2.17%
45,968 $407,000
Q3 2020

Nov 09, 2020

SELL
$9.57 - $27.05 $250,963 - $709,359
-26,224 Reduced 36.82%
44,992 $522,000
Q2 2020

Aug 13, 2020

BUY
$7.14 - $31.69 $108,220 - $480,325
15,157 Added 27.04%
71,216 $1.92 Million
Q1 2020

May 14, 2020

BUY
$2.98 - $14.09 $47,557 - $224,862
15,959 Added 39.8%
56,059 $417,000
Q4 2019

Feb 14, 2020

BUY
$1.97 - $3.72 $10,047 - $18,972
5,100 Added 14.57%
40,100 $132,000
Q3 2019

Nov 13, 2019

BUY
$2.05 - $3.02 $29,109 - $42,884
14,200 Added 68.27%
35,000 $72,000
Q2 2019

Aug 09, 2019

BUY
$2.29 - $4.1 $47,632 - $85,279
20,800 New
20,800 $61,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $459M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.